Clinical TrialsClinical trials are offered to Sturdy Memorial patients as a way of giving them more treatment options and enhanced quality of care. These are the same clinical trials that are being conducted in large, teaching hospitals, which enable patients to explore innovative, state-of-the-art cancer treatments close to home. The following is a list of ongoing breast cancer clinical trials at Sturdy Memorial Hospital. CALGB 40101: Cyclophosphamide and doxorubicin (CA) versus paclitaxel as adjuvant therapy for women with 0-3 positive axillary lymph nodes. This study is for women with breast cancer that has been removed by surgery, with either no lymph nodes or as many as 3 lymph nodes in the arm involved with cancer. CALGB 70301: Quality of life, employment, and informal care cost analysis in women receiving adjuvant chemotherapy for node-negative breast cancer (Companion to CALGB 40101). CALGB 369901: Observational cohort study: Chemotherapy decisions and outcomes in women age 65 or older with operable, newly diagnosed breast cancer. Sturdy Memorial Hospital is taking part in a new research study looking at the everyday issues that women 65 or older face when making decisions about treatment for breast cancer. ECOG PACCT-1: Program for the Assessment of Clinical Cancer Tests: Trial Assigning Individualized Options for Treatment: The TAILORx Trial. This trial will examine whether genes that are frequently associated with risk of recurrence for women with early-state breast cancer can be used to assign patients to the most appropriate and effective treatment. NSABP B-40: Randomized phase III trial of neoadjuvant therapy in patients with palpable and operable breast cancer evaluating the effect on pCR of adding capecitabine or gemcitabine to docetaxel when administered before AC with or without bevacizumab. NSABP B-42: Letrozole in treating postmenopausal women who have received hormone therapy for hormone receptor-positive breast cancer. Available at Shields Radiation MansfieldNSABP B-39: Randomized phase III study of conventional whole breast irradiation vs. partial breast irradiation for stage 0, I, II breast cancer. Our partner, Shields Radiation Oncology Center Mansfield, is a Radiation Therapy Oncology Group (RTOG) member and a part of the Clinical Trials Cooperative Group Program, which offers over 60 clinical trials. Click here to visit the trials section of the Center's website. or click here for more information about this trial. To learn more, and find out if you are eligible to participate in a clinical research trial, please contact the clinical research nurse at 508-236-7059. |
|
 |
|